---
type: "Symbol"
title: "AIM IMMUNOTECH INC (AIMID.US) — Community Discussions"
description: "Community discussions about this stock, including analyst opinions, earnings analysis, and investment strategies from verified financial professionals and active investors."
locale: "en"
url: "https://longbridge.com/en/quote/AIMID.US/topics.md"
symbol: "AIMID.US"
parent: "https://longbridge.com/en/quote/AIMID.US.md"
count: 7
datetime: "2026-03-08T02:11:20.060Z"
locales:
  - [en](https://longbridge.com/en/quote/AIMID.US/topics.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/AIMID.US/topics.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/AIMID.US/topics.md)
---

# AIM IMMUNOTECH INC (AIMID.US) — Community Discussions

### [[Zhenzhuo Institutional View] Tencent Holdings (00700.HK): High-quality Growth Driven by Multiple Engines](https://longbridge.com/en/topics/37022525.md)

- Author: [真灼财经](https://longbridge.com/en/profiles/1067948.md)
- Datetime: 2025-12-10T03:06:10.000Z
- Comments: 0
- $TENCENT(00700.HK) with its profound game R&amp;D and operational capabilities, is consolidating its market leadership through diversified product pipelines. The company plans to launch key games such

### [Tencent Holdings reported third-quarter revenue of…](https://longbridge.com/en/topics/36312439.md)

- Author: [外汇交易员](https://longbridge.com/en/profiles/19266896.md)
- Datetime: 2025-11-13T08:44:32.000Z
- Comments: 0
- Tencent Holdings reported third-quarter revenue of 192.869 billion yuan (estimated 188.8 billion yuan), a year-on-year increase of 15%; quarterly net profit was 63.133 billion yuan (estimated 55.88 bi

### [$AIM ImmunoTech(AIM.US) Is there still anyone in? …](https://longbridge.com/en/topics/32345894.md)

- Author: [亿万金](https://longbridge.com/en/profiles/19971726.md)
- Datetime: 2025-07-29T12:20:33.000Z
- Comments: 0
- $AIM ImmunoTech(AIM.US) Is there still anyone in? It's at its historical low price~🤣

### [$AIM ImmunoTech(AIM.US)Why did it surge in pre-mar…](https://longbridge.com/en/topics/32323753.md)

- Author: [Ian_6Mh7zk](https://longbridge.com/en/profiles/19817393.md)
- Datetime: 2025-07-29T02:51:36.000Z
- Comments: 1
- $AIM ImmunoTech(AIM.US)Why did it surge in pre-market but keep falling during the session? A 70% drop, isn't this just reckless?

**Comments:**

- **亿万金 · 2025-07-29T08:12:42.000Z**: The problem is that no one is trading now~

### [$AIM ImmunoTech(AIM.US)Has it been halved?](https://longbridge.com/en/topics/32312848.md)

- Author: [江西富一代](https://longbridge.com/en/profiles/20745661.md)
- Datetime: 2025-07-28T17:14:32.000Z
- Comments: 1
- $AIM ImmunoTech(AIM.US)Has it been halved?

**Comments:**

- **亿万金 · 2025-07-28T21:16:22.000Z**: Wait until tomorrow

### [$AIM ImmunoTech(AIM.US) Is anyone still in there? …](https://longbridge.com/en/topics/32302204.md)

- Author: [亿万金](https://longbridge.com/en/profiles/19971726.md)
- Datetime: 2025-07-28T14:26:45.000Z
- Comments: 28
- $AIM ImmunoTech(AIM.US) Is anyone still in there? Hanging on the tree~

**Comments:**

- **尝尝咸淡 · 2025-07-29T10:35:09.000Z**: Now it's 4 yuan.
- **wawo · 2025-07-28T19:36:32.000Z**: This is no fun, I surrender and retreat.
- **wawo · 2025-07-28T16:49:45.000Z**: Go to sleep. No idea what's going on after hours.
- *[... 23 more comments →](https://longbridge.com/en/topics/32302204.md)*

### [思摩爾迎來新利好](https://longbridge.com/en/topics/2210740.md)

- Author: [未來戰士](https://longbridge.com/en/profiles/7451916.md)
- Datetime: 2022-03-29T14:33:47.000Z
- Comments: 2
- 「文章分享」據深圳特區報，深圳企業思摩爾科技正在與美國藥企合作研發新冠肺炎吸入式療法，研究表明，該吸入式療法能將新冠病毒傳染性病毒生成量降低 90％。“我們正與美國上市藥企 AIM 保持密切合作，為其藥物安普利近 (Ampligen) 提供安全霧化吸入裝置，攜手探索霧化技術在新冠肺炎治療等醫療領域的應用。” 思摩爾科技首席科學家及全球研發總監石志強介紹説，“該合作已經進入到臨牀研究階段...

**Comments:**

- **nozt3e · 2022-03-29T14:35:46.000Z · 👍 1**: 呢隻好似都唔錯 可以研究下

## References

- [AIM IMMUNOTECH INC (AIMID.US)](https://longbridge.com/en/quote/AIMID.US.md)


> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/AIMID.US/topics.md) | [繁體中文](https://longbridge.com/zh-HK/quote/AIMID.US/topics.md)
